Hennion & Walsh Asset Management, Inc. Genetic Technologies LTD Transaction History

Hennion & Walsh Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$0.0 - $0.0 $0 - $0	-10,939 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.01 $0 - $109	10,939 New	10,939 $21,000
Q3 2021 Nov 12, 2021	SELL	$0.0 - $0.01 $0 - $109	-10,962 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.0 - $0.02 $0 - $17	890 Added 8.84%	10,962 $47,000
Q1 2021 May 17, 2021	BUY	$0.0 - $0.01 $0 - $100	10,072 New	10,072 $42,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.